# JLK

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jlk

- Industry: Medical Devices & Equipment
- Headquarters: Cheongju-si, South Korea
- Website: www.jlkgroup.com
- Total disclosed funding: $12M
- Latest round: Series B (Feb 6, 2018)
- Investors on record: 5

## About

JLK, Inc., based in Cheongju-si, South Korea, specializes in providing advanced web server solutions, enhancing operational efficiency and performance for businesses across various sectors globally.Founded in 2014, JLK, Inc. operates as a technology firm focused on web server solutions. The company underwent a significant transformation in December 2019, when it raised KRW 18 billion through an IPO, selling 2 million shares at KRW 9,000 each on the KOSDAQ. The founder, whose history in technology ventures is notable, led JLK to capitalize on a growing market demand for their offerings. Today, it continues to serve clients from its headquarters in Cheongju-si, South Korea.JLK, Inc.’s primary product is the nginx HTTP server, known for its high-performance capabilities as a web server and reverse proxy. This technology addresses various use cases such as web hosting, load balancing, and content delivery, catering to clients from small enterprises to large corporations across sectors like e-commerce, media, and technology. The company markets its solutions globally, with a strong presence in North America, Europe, and Asia-Pacific, focusing on the enhancement of operational efficiency and reliability for businesses reliant on robust web infrastructure.In the most recent fiscal year of 2024, JLK, Inc. reported a revenue of KRW 1,047,332,458.90, while the EBITDA for the same year was KRW -8,804,817,649.70, indicating operational challenges amidst its revenue generation strategy.In December 2019, JLK, Inc. completed an IPO raising KRW 18 billion, aimed at launching regional operations in the US and Europe while expanding its workforce. The company plans to release new product offerings to enhance its service capabilities and penetrate these new markets by 2025.

## Funding rounds

- Series B, Feb 6, 2018, $8.3M — KB Investment, InterVest, SL Investment, BNH Investment, Medici Investment
- Series A, Feb 4, 2017, $1.3M — InterVest, Medici Investment
- Series A, Dec 28, 2016, $2M — KB Investment, SL Investment, BNH Investment

## Investors

- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series A, Series B
- SL Investment (https://capitalatlas.ai/funds/sl-investment) — Series A, Series B
- BNH Investment (https://capitalatlas.ai/funds/bnh-investment) — Series A, Series B
- InterVest (https://capitalatlas.ai/funds/intervest) — Series A, Series B
- Medici Investment (https://capitalatlas.ai/funds/medici-investment) — Series A, Series B
